z-logo
open-access-imgOpen Access
Synthesis and Optimization of MoS 2 @Fe 3 O 4 ‐ICG/Pt(IV) Nanoflowers for MR/IR/PA Bioimaging and Combined PTT/PDT/Chemotherapy Triggered by 808 nm Laser
Author(s) -
Liu Bei,
Li Chunxia,
Chen Guanying,
Liu Bin,
Deng Xiaoran,
Wei Yi,
Xia Jun,
Xing Bengang,
Ma Ping'an,
Lin Jun
Publication year - 2017
Publication title -
advanced science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.388
H-Index - 100
ISSN - 2198-3844
DOI - 10.1002/advs.201600540
Subject(s) - indocyanine green , materials science , photothermal therapy , nanotechnology , nanocomposite , nanocages , nuclear chemistry , chemistry , organic chemistry , medicine , surgery , catalysis
Elaborately designed biocompatible nanoplatforms simultaneously achieving multimodal bioimaging and therapeutic functions are highly desirable for modern biomedical applications. Herein, uniform MoS 2 nanoflowers with a broad size range of 80–180 nm have been synthesized through a facile, controllable, and scalable hydrothermal method. The strong absorbance of MoS 2 nanoflowers at 808 nm imparts them with high efficiency and stability of photothermal conversion. Then a novel multifunctional composite of MoS 2 @Fe 3 O 4 ‐ICG/Pt(IV) (labeled as Mo@Fe‐ICG/Pt) is designed by covalently grafting Fe 3 O 4 nanoparticles with polyethylenimine (PEI) functionalized MoS 2 , and then loading indocyanine green molecules (ICG, photosensitizers) and platinum (IV) prodrugs (labeled as Pt(IV) prodrugs) on the surface of MoS 2 @Fe 3 O 4 . The resulting Mo@Fe‐ICG/Pt nanocomposites can achieve excellent magnetic resonance/infrared thermal/photoacoustic trimodal biomaging as well as remarkably enhanced antitumor efficacy of combined photothermal therapy, photodynamic therapy, and chemotherapy triggered by a single 808 nm NIR laser, thus leading to an ideal nanoplatform for cancer diagnosis and treatment in future.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here